Transcription factor Sp3 is silenced through SUMO modification by PIAS1

被引:221
作者
Sapetschnig, A
Rischitor, G
Braun, H
Doll, A
Schergaut, M
Melchior, F
Suske, G
机构
[1] Inst Mol Biol & Tumorforsch, D-35037 Marburg, Germany
[2] Max Planck Inst Biochem, D-82152 Martinsried, Germany
关键词
E3; ligase; inhibitory domain; PIAS1; SUMO; transcription factor Spa;
D O I
10.1093/emboj/cdf510
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Sp3 is a ubiquitous transcription factor closely related to Sp1. Here we show that Sp3 is a target for SUMO modification in vivo and in vitro. SUMO modification of Sp3 occurs at a single lysine located between the second glutamine-rich activation domain and the DNA-binding domain. Mutational analyses identified the sequence IKXE as essential for SUMO conjugation to Spa. We identified the protein inhibitor of activated STAT1 (PIAS1) as an interaction partner of Sp3 and Ubc9. Moreover, PIAS1 strongly stimulated SUMO conjugation to Sp3, thus acting as an E3 ligase for SUMO conjugation to Sp3. All mutations that prevented SUMO modification in vitro strongly enhanced the transcriptional activity of Sp3, showing that SUMO modification silences Sp3 activity. SUMO-modified Sp3 bound to DNA with similar specificity and affinity as unmodified Sp3. However, DNA-bound Sp3 did not act as a substrate for SUMO modification.
引用
收藏
页码:5206 / 5215
页数:10
相关论文
共 46 条
[31]   A testis-specific androgen receptor coregulator that belongs to a novel family of nuclear proteins [J].
Moilanen, AM ;
Karvonen, U ;
Poukka, H ;
Yan, W ;
Toppari, J ;
Jänne, OA ;
Palvimo, JJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (06) :3700-3704
[32]   c-Jun and p53 activity is modulated by SUMO-1 modification [J].
Müller, S ;
Berger, M ;
Lehembre, F ;
Seeler, JS ;
Haupt, Y ;
Dejean, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (18) :13321-13329
[33]   Sumo, ubiquitin's mysterious cousin [J].
Müller, S ;
Hoege, C ;
Pyrowolakis, G ;
Jentsch, S .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2001, 2 (03) :202-210
[34]   The nucleoporin RanBP2 has SUMO1 E3 ligase activity [J].
Pichler, A ;
Gast, A ;
Seeler, JS ;
Dejean, A ;
Melchior, F .
CELL, 2002, 108 (01) :109-120
[35]   Covalent modification of the androgen receptor by small ubiquitin-like modifier 1 (SUMO-1) [J].
Poukka, H ;
Karvonen, U ;
Jänne, OA ;
Palvimo, JJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (26) :14145-14150
[36]   SUMO-1 modification activates the transcriptional response of p53 [J].
Rodriguez, MS ;
Desterro, JMP ;
Lain, S ;
Midgley, CA ;
Lane, DP ;
Hay, RT .
EMBO JOURNAL, 1999, 18 (22) :6455-6461
[37]   SUMO-1 conjugation in vivo requires both a consensus modification motif and nuclear targeting [J].
Rodriguez, MS ;
Dargemont, C ;
Hay, RT .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (16) :12654-12659
[38]   PIASy, a nuclear matrix-associated SUMO E3 ligase, represses LEF1 activity by sequestration into nuclear bodies [J].
Sachdev, S ;
Bruhn, L ;
Sieber, H ;
Pichler, A ;
Melchior, F ;
Grosschedl, R .
GENES & DEVELOPMENT, 2001, 15 (23) :3088-3103
[39]   The nuclear dot protein Sp100, characterization of domains necessary for dimerization, subcellular localization, and modification by small ubiquitin-like modifiers [J].
Sternsdorf, T ;
Jensen, K ;
Reich, B ;
Will, H .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (18) :12555-12566
[40]  
Suske G, 2000, Methods Mol Biol, V130, P175